Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nada Alachkar

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|March 8, 2013
Angiotensin antibodies and focal segmental glomerulosclerosisNada Alachkar, Gaurav Gupta, Robert A Montgomery
Advances in Chronic Kidney Disease|August 30, 2014
Permeability factors in focal and segmental glomerulosclerosisJochen Reiser, Cynthia C Nast, Nada Alachkar
BMC Nephrology|May 22, 2020
Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experienceSam Kant, Anshul Bhalla, Sami Alasfar, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 18, 2012
Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograftNada Alachkar, Serena M Bagnasco, Robert A Montgomery
BMC Nephrology|July 4, 2020
Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuriaMohammad Abuzeineh, Amtul Aala, Sami Alasfar, et al.
Cell and Tissue Research|April 28, 2021
Immune-mediated entities of (primary) focal segmental glomerulosclerosisFabian Braun, Inka Homeyer, Nada Alachkar, et al.
Transplantation|March 20, 2013
Reply to "Defining the benefits of desensitization therapy"Andrew L Singer, Nada Alachkar, Robert A Montgomery, et al.
Seminars in Nuclear Medicine|November 30, 2010
Molecular imaging of the kidneysZsolt Szabo, Nada Alachkar, Jinsong Xia, et al.
Transplantation Proceedings|February 12, 2021
Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant RecipientsMohammad Abuzeineh, Yousuf Kyeso, Mary Carmelle Philogene, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 3, 2009
Incidental discovery of a renal cell carcinoma on native kidney biopsyC John Sperati, Nada Alachkar, Ronald Rodriguez, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|March 8, 2013
Angiotensin antibodies and focal segmental glomerulosclerosisNada Alachkar, Gaurav Gupta, Robert A Montgomery
Advances in Chronic Kidney Disease|August 30, 2014
Permeability factors in focal and segmental glomerulosclerosisJochen Reiser, Cynthia C Nast, Nada Alachkar
BMC Nephrology|May 22, 2020
Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experienceSam Kant, Anshul Bhalla, Sami Alasfar, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 18, 2012
Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograftNada Alachkar, Serena M Bagnasco, Robert A Montgomery
BMC Nephrology|July 4, 2020
Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuriaMohammad Abuzeineh, Amtul Aala, Sami Alasfar, et al.
Cell and Tissue Research|April 28, 2021
Immune-mediated entities of (primary) focal segmental glomerulosclerosisFabian Braun, Inka Homeyer, Nada Alachkar, et al.
Transplantation|March 20, 2013
Reply to "Defining the benefits of desensitization therapy"Andrew L Singer, Nada Alachkar, Robert A Montgomery, et al.
Seminars in Nuclear Medicine|November 30, 2010
Molecular imaging of the kidneysZsolt Szabo, Nada Alachkar, Jinsong Xia, et al.
Transplantation Proceedings|February 12, 2021
Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant RecipientsMohammad Abuzeineh, Yousuf Kyeso, Mary Carmelle Philogene, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 3, 2009
Incidental discovery of a renal cell carcinoma on native kidney biopsyC John Sperati, Nada Alachkar, Ronald Rodriguez, et al.
Pageof 6